Active substance:
- Clostridium perfringens, type B, strain ATCC 3626, Inactivated
- Clostridium perfringens, type C, strain ATCC 3628, Inactivated
- Clostridium perfringens, type D, strain ATCC 3629, Inactivated
- Clostridium perfringens, type B, strain ATCC 3626, type C, strain ATCC 3628 and type D, strain ATCC 3629, beta toxoid
- Clostridium perfringens, type B, strain ATCC 3626, type C, strain ATCC 3628 and type D, strain ATCC 3629, epsilon toxoid
Route of administration:
-
Subcutaneous use
Pharmaceutical form:
-
Suspension for injection
Target species:
-
Sheep (lamb)
-
Goat (kid)